JP2006225396A5 - - Google Patents

Download PDF

Info

Publication number
JP2006225396A5
JP2006225396A5 JP2006079226A JP2006079226A JP2006225396A5 JP 2006225396 A5 JP2006225396 A5 JP 2006225396A5 JP 2006079226 A JP2006079226 A JP 2006079226A JP 2006079226 A JP2006079226 A JP 2006079226A JP 2006225396 A5 JP2006225396 A5 JP 2006225396A5
Authority
JP
Japan
Prior art keywords
protein
phosphorylated
antibody
site
binds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006079226A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006225396A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2006225396A publication Critical patent/JP2006225396A/ja
Publication of JP2006225396A5 publication Critical patent/JP2006225396A5/ja
Pending legal-status Critical Current

Links

JP2006079226A 2000-09-27 2006-03-22 タンパク質に対するホスホキナーゼ活性の定量のための方法 Pending JP2006225396A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23562000P 2000-09-27 2000-09-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002530779A Division JP2004516823A (ja) 2000-09-27 2001-09-27 タンパク質に対するホスホキナーゼ活性の定量のための方法

Publications (2)

Publication Number Publication Date
JP2006225396A JP2006225396A (ja) 2006-08-31
JP2006225396A5 true JP2006225396A5 (https=) 2008-10-23

Family

ID=22886277

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002530779A Withdrawn JP2004516823A (ja) 2000-09-27 2001-09-27 タンパク質に対するホスホキナーゼ活性の定量のための方法
JP2006079226A Pending JP2006225396A (ja) 2000-09-27 2006-03-22 タンパク質に対するホスホキナーゼ活性の定量のための方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002530779A Withdrawn JP2004516823A (ja) 2000-09-27 2001-09-27 タンパク質に対するホスホキナーゼ活性の定量のための方法

Country Status (7)

Country Link
US (4) US20030162230A1 (https=)
EP (3) EP2298814A3 (https=)
JP (2) JP2004516823A (https=)
AT (1) ATE416385T1 (https=)
CA (1) CA2423979C (https=)
DE (1) DE60136840D1 (https=)
WO (1) WO2002027017A2 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040014082A1 (en) * 2000-08-11 2004-01-22 Invitrogen Corporation Highly homogeneous molecular markers for electrophoresis
US20030162230A1 (en) * 2000-09-27 2003-08-28 Reagan Kevin J. Method for quantifying phosphokinase activity on proteins
GB0208104D0 (en) * 2002-04-09 2002-05-22 Univ Dundee Method
EP1506286B1 (en) 2002-05-24 2014-03-19 Merck Sharp & Dohme Corp. Neutralizing human anti-igfr antibody
US7619059B2 (en) 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
CA2445420A1 (en) 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
US7727752B2 (en) 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
EP1668146B1 (en) 2003-09-25 2014-11-12 Life Technologies Corporation Homogeneous populations of molecules
US7326567B2 (en) 2003-11-12 2008-02-05 Schering Corporation Plasmid system for multigene expression
TW200526684A (en) 2003-11-21 2005-08-16 Schering Corp Anti-IGFR1 antibody therapeutic combinations
PT1828249E (pt) 2004-12-03 2011-02-25 Schering Corp Biomarcadores para a pré-selecção de pacientes para terapêutica anti-igf1r
US7807789B2 (en) * 2004-12-21 2010-10-05 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
WO2007005605A2 (en) * 2005-07-01 2007-01-11 Washington University In St. Louis Phosphospecific chemokine receptor antibodies
WO2007133688A2 (en) * 2006-05-12 2007-11-22 Cell Signaling Technology, Inc. Reagents for the detection of tyrosine phosphorylation in brain ischemia signaling pathways
WO2008147687A1 (en) * 2007-05-21 2008-12-04 Mayo Foundation For Medical Education And Research Treating pancreatitis
KR101612442B1 (ko) 2008-05-13 2016-04-15 삼성전자주식회사 컨텐츠 시청 제한 정보의 제공 및 이용을 위한 방법 및장치
AU2011235595B2 (en) * 2010-03-29 2016-06-09 Central Adelaide Local Health Network Inc. A method of modulating protein 14-3-3 functionality by facilitating or inhibiting phosphorylation
EP2614372B1 (en) * 2010-09-07 2018-07-25 Stephen G. Marx Kit for monitoring, detecting and staging gvhd
US20170016900A1 (en) 2010-09-07 2017-01-19 Stephen G. Marx Kit for monitoring, detecting and staging gvhd
US9200068B2 (en) 2012-12-18 2015-12-01 Regents Of The University Of Minnesota Compositions and methods related to tauopathy
AU2014368696A1 (en) 2013-12-20 2016-06-02 F. Hoffmann-La Roche Ag Humanized anti-Tau(pS422) antibodies and methods of use
EP4321165A3 (en) * 2013-12-27 2024-08-21 National University Corporation Tokyo Medical and Dental University Method for diagnosis of alzheimer's disease and frontotemporal lobar degeneration, diagnostic agent, therapeutic agent, and screening method for said agents
AU2015240088B2 (en) * 2014-03-31 2021-07-22 Merck Patent Gmbh Method for detecting protein modifications using specific antibodies
AR100978A1 (es) 2014-06-26 2016-11-16 Hoffmann La Roche LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS
WO2016207245A1 (en) 2015-06-24 2016-12-29 F. Hoffmann-La Roche Ag Humanized anti-tau(ps422) antibodies and methods of use
JO3711B1 (ar) * 2015-07-13 2021-01-31 H Lundbeck As أجسام مضادة محددة لبروتين تاو وطرق استعمالها
JP7040774B2 (ja) * 2016-03-01 2022-03-23 マックォーリー・ユニバーシティ 神経学的症状の治療のためのリン酸化ｔａｕ及びｐ３８ガンマの使用
PH12018502613B1 (en) 2016-07-12 2023-02-01 H Lundbeck As Antibodies specific for hyperphosphorylated tau and methods of use thereof
ES2791962T3 (es) * 2016-11-21 2020-11-06 Univ Ruhr Bochum Ensayo combinado para el diagnóstico diferencial de la enfermedad de Alzheimer
CN110267985B (zh) 2017-01-04 2023-05-23 H.隆德贝克有限公司 用于治疗眼科疾病的特异性针对过度磷酸化τ蛋白的抗体
AU2018388549B2 (en) * 2017-12-18 2023-06-01 Yale University Compounds and compositions for treating fibrosis
US10591492B2 (en) 2018-03-05 2020-03-17 Janssen Pharmaceutica Nv Assays to detect neurodegeneration
CA3093200A1 (en) 2018-03-05 2019-09-12 Janssen Pharmaceutica Nv Anti-phf-tau antibodies and uses thereof
US11085935B2 (en) * 2018-05-03 2021-08-10 Washington University Methods of treating based on site-specific tau phosphorylation
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
CA3150369A1 (en) 2019-09-10 2021-03-18 Randall Bateman Blood-based assay for diagnosing and treating based on site-specific tau phosphorylation

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2354288C2 (de) 1973-10-30 1976-01-02 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von Aminophenylalkyläthern
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US5733734A (en) * 1991-08-14 1998-03-31 The Trustees Of The University Of Pennsylvania Method of screening for Alzheimer's disease or disease associated with the accumulation of paired helical filaments
JPH05126833A (ja) 1991-10-31 1993-05-21 Tosoh Corp チロシンキナ−ゼ活性の免疫化学的測定法及びそのキツト
DK0618968T3 (da) * 1991-12-06 2000-04-10 Max Planck Gesellschaft Midler til diagnostisering og behandling af Alzheimer's sygdom
EP0544942A1 (en) * 1991-12-06 1993-06-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Novel tools for the diagnosis and treatment of Alzheimer disease
WO1993021230A1 (en) 1992-04-10 1993-10-28 Dana-Farber Cancer Institute, Inc. Activation-state-specific phosphoprotein immunodetection
WO1994013795A1 (en) * 1992-12-14 1994-06-23 N.V. Innogenetics S.A. Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
US6924361B1 (en) 1993-11-02 2005-08-02 Phosphoproteomics Llc Phosphopeptide-specific antibodies that are activity specific; methods of production and antibody uses
CA2175893C (en) * 1993-11-23 2010-06-22 Paul J. Godowski Protein tyrosine kinases named rse
ES2270421T3 (es) 1993-12-21 2007-04-01 Innogenetics N.V. Anticuerpos monoclonales especificos para phf-tau, hibridomas que secretan los mismos, reconocimiento de antigeno por estos anticuerpos y sus aplicaciones.
US6348310B1 (en) * 1994-03-04 2002-02-19 Promega Corporation Quantitation of individual protein kinase activity
US5763198A (en) * 1994-07-22 1998-06-09 Sugen, Inc. Screening assays for compounds
WO1996004309A1 (en) * 1994-07-29 1996-02-15 Innogenetics N.V. Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications
US6001580A (en) * 1995-03-28 1999-12-14 Takeda Chemical Industries, Inc. Method for assaying ERK2 map kinase
ATE248189T1 (de) * 1997-11-07 2003-09-15 Vasopharm Biotech Gmbh Antikörper gegen vasp (vasodilator-stimulated phosphoprotein), hybridomzellen für deren gewinnung, und deren verwendung
DK1036192T3 (da) * 1997-12-05 2003-06-10 Upjohn Co Fluorescensbaserede screeningsanalyser med høj hastighedforproteinkinaser og phosphataser
GB9803399D0 (en) * 1998-02-19 1998-04-15 Imp Cancer Res Tech Protein kinase c
JP2000034300A (ja) * 1998-07-17 2000-02-02 Mitsubishi Chemicals Corp 抗リン酸化タウ蛋白質抗体及びそれを用いるアルツハイマー病の検出方法
US6309863B1 (en) 1999-01-25 2001-10-30 Brookhaven Science Associates Methods for generating phosphorylation site-specific immunological reagents
DE60045586D1 (de) * 1999-06-09 2011-03-10 Molecular Devices Inc Testverfahren zur messung der phosphorylierung
JP4828752B2 (ja) 1999-08-04 2011-11-30 株式会社医学生物学研究所 サイクリン／ｃｄｋ複合体のリン酸化酵素活性測定方法
ATE342509T1 (de) * 2000-01-24 2006-11-15 Innogenetics Nv Diagnose von tauopathien durch bestimmung des verhältnisses von tau/phospho-tau
US20030166016A1 (en) 2000-04-28 2003-09-04 Foster Barbara A. Assay methods for cyclin dependent kinases
US20030162230A1 (en) 2000-09-27 2003-08-28 Reagan Kevin J. Method for quantifying phosphokinase activity on proteins

Similar Documents

Publication Publication Date Title
JP2006225396A5 (https=)
JP2004516823A5 (https=)
Nordin et al. Kinetic studies of small molecule interactions with protein kinases using biosensor technology
Engholm‐Keller et al. Technologies and challenges in large‐scale phosphoproteomics
Tsai et al. Sequential phosphoproteomic enrichment through complementary metal-directed immobilized metal ion affinity chromatography
WO2020123319A3 (en) Methods of using master / copy arrays for spatial detection
JP2014508298A5 (https=)
CA2423979A1 (en) Method for quantifying phosphokinase activity on proteins
JP2006502416A5 (https=)
WO2009037659A3 (en) Magnetic detection of small entities
ATE485514T1 (de) Immunoassay mit mehreren analyten
JP2004533226A5 (https=)
Cann et al. Measuring kinase activity—a global challenge
GB2490404B (en) Methods for determining ligand binding to a target protein using a thermal shift assay
WO2013132347A3 (en) Improved elisa immunoassay for calprotectin
Vowinckel et al. Histaminylation of glutamine residues is a novel posttranslational modification implicated in G-protein signaling
WO2008082713A3 (en) Integrated semiconductor bioarray
JP2016528236A5 (https=)
WO2005007090A3 (en) Inhibitors of the map kinase pathway
JP2011102805A5 (https=)
Chen et al. Target-protecting dumbbell molecular probe against exonucleases digestion for sensitive detection of ATP and streptavidin
Kabiraz et al. Highly sensitive detection of clenbuterol in urine sample by using surface plasmon resonance immunosensor
Kim et al. Semi-continuous, real-time monitoring of protein biomarker using a recyclable surface plasmon resonance sensor
JP2015531487A5 (https=)
JP2009543555A5 (https=)